MRI of the cervical nerve roots in the diagnosis of chronic inflammatory demyelinating polyradiculoneuropathy: A single-institution, retrospective case-control study

BMJ Open

Volumn 3, Issue 8, 2013, Pages

  Tanaka, Kanta ^a   Mori, Nobuyuki ^a   Yokota, Yusuke ^a   Suenaga, Toshihiko ^a  

^a TENRI HOSPITAL   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CASE CONTROL STUDY; CERVICAL SPINE; CHRONIC INFLAMMATORY DEMYELINATING POLYRADICULONEUROPATHY; CLINICAL ARTICLE; CONTRAST TO NOISE RATIO; CONTROLLED STUDY; DIAGNOSTIC PROCEDURE; HUMAN; NERVE BIOPSY; NERVE ROOT; NERVE TO MUSCLE; NEUROIMAGING; NEUROLOGIC EXAMINATION; NUCLEAR MAGNETIC RESONANCE IMAGING; PARAMETERS; POLYRADICULONEUROPATHY; STERNOCLEIDOMASTOID MUSCLE; SURAL NERVE;

EID: 84885356291     PISSN: None     EISSN: 20446055     Source Type: Journal    
DOI: 10.1136/bmjopen-2013-003443     Document Type: Article

References (32)

1. Dyck PJ, Lais AC, Ohta M, et al Chronic inflammatory polyradiculoneuropathy. Mayo Clin Proc 1975;50:621-37.
2. Vallat JM, Sommer C, Magy L. Chronic inflammatory demyelinating polyradiculoneuropathy: diagnostic and therapeutic challenges for a treatable condition. Lancet Neurol 2010;9:402-12.
3. American Academy of Neurology AIDS Task Force. Research criteria for diagnosis of chronic inflammatory demyelinating polyneuropathy (CIDP). Neurology 1991;41:617-18.
4. Sander HW, Latov N. Research criteria for defining patients with CIDP. Neurology 2003;60(Suppl 3):S8-15.
5. Hughes R, Bensa S, Willison H., et al Randomized controlled trial of intravenous immunoglobulin versus oral prednisolone in chronic inflammatory demyelinating polyradiculoneuropathy. Ann Neurol 2001;50:195-201. (Pubitemid 32738144)
6. Joint Task Force of the EFNS and the PNS. European Federation of Neurological Societies/Peripheral Nerve Society Guideline on management of chronic inflammatory demyelinating polyradiculoneuropathy: report of a joint task force of the European Federation of Neurological Societies and the Peripheral Nerve Society. Eur J Neurol 2006;13:326-32
7. and J Peripher Nerv Syst 2005;10:220-8.
8. Koski CL, Baumgarten M, Magder L.S., et al Derivation and validation of diagnostic criteria for chronic inflammatory demyelinating polyneuropathy. J Neurol Sci 2009;277:1-8.
9. Joint Task Force of the EFNS and the PNS. European Federation of Neurological Societies/Peripheral Nerve Society Guideline on management of chronic inflammatory demyelinating polyradiculoneuropathy: report of a joint task force of the European Federation of Neurological Societies and the Peripheral Nerve Society-First Revision. Eur J Neurol 2010;17:356-63.
10. Rajabally YA, Simpson BS, Beri S, et al Epidemiologic variability of chronic inflammatory demyelinating polyneuropathy with different diagnostic criteria: study of a UK population. Muscle Nerve 2009;39:432-8.
11. Duggins AJ, McLeod JG, Pollard J.D., et al Spinal root and plexus hypertrophy in chronic inflammatory demyelinating polyneuropathy. Brain 1999;122:1383-90. (Pubitemid 29324858)
12. Tazawa K, Matsuda M, Yoshida T., et al Spinal nerve root hypertrophy on MRI: clinical significance in the diagnosis of chronic inflammatory demyelinating polyradiculoneuropathy. Intern Med 2008;47:2019-24.
13. Adachi Y, Sato N, Okamoto T., et al Brachial and lumbar plexuses in chronic inflammatory demyelinating polyradiculoneuropathy: MRI assessment including apparent diffusion coefficient. Neuroradiology 2011;53:3-11.
14. French CIDP Study Group. Recommendations on diagnostic strategies for chronic inflammatory demyelinating polyradiculoneuropathy. J Neurol Neurosurg Psychiatry 2008;79:115-18.
15. Tanaka K, Mori N, Yokota Y., et al Is quantitative assessment of cervical nerve hypertrophy by MRI effective for the diagnosis of chronic inflammatory demyelinating polyradiculoneuropathy? A single-institution, retrospective case-control study [abstract]. Eur J Neurol 2012;19(Suppl 2):P408.
16. Newman TB, Browner WS, Cummings S.R., et al Designing studies of medical tests. In: Hulley SB, Cummings SR, Browner WS, et al., eds. Designing clinical research. Philadelphia, PA: Lippincott Williams & Wilkins, 2007:183-204.
17. Mygland Å, Monstad P, Vedeler C. Onset and course of chronic inflammatory demyelinating polyneuropathy. Muscle Nerve 2005;31:589-93. (Pubitemid 40577781)
18. Plasma Exchange/Sandoglobulin Guillain-Barré Syndrome Trial Group. Randomized trial of plasma exchange, intravenous immunoglobulin, and combined treatments in Guillain-Barré syndrome. Lancet 1997;349:225-30.
19. Matsuoka N, Kohriyama T, Ochi K., et al Detection of cervical nerve root hypertrophy by ultrasonography in chronic inflammatory demyelinating polyradiculoneuropathy. J Neurol Sci 2004;219:15-21. (Pubitemid 38405992)
20. Jeong WK, Byun JH, Lee S.S., et al Gadobenate dimeglumine-enhanced liver MR imaging in cirrhotic patients: quantitative and qualitative comparison of 1-hour and 3-hour delayed images. J Magn Reson Imaging 2011;33:889-97.
21. Obuchowski NA. Receiver operating characteristic curves and their use in radiology. Radiology 2003;229:3-8. (Pubitemid 37152094)
22. Hanley JA, McNeil BJ The meaning and use of the area under a receiver operating characteristic (ROC) curve. Radiology 1982;143:29-36. (Pubitemid 12142173)
23. Bland JM, Altman DG Statistical methods for assessing agreement between two methods of clinical measurement. Lancet 1986; 1:307-10. (Pubitemid 16134762)
24. Steichen TJ, Cox NJ A note on the concordance correlation coefficient. Stata J 2002;2:183-9.
25. Rosseti AO, Oddo M, Logroscino G., et al Prognostication after cardiac arrest and hypothermia: a prospective study. Ann Neurol 2010;67:301-7.
26. Thompson PD, Thomas PK Clinical patterns of peripheral neuropathy. In: Dyck PJ, Thomas PK, eds. Peripheral neuropathy. 4th edn. Philadelphia, PA: Elsevier Saunders, 2005: 1137-61.
27. Blumbergs P, Reilly P, Vink R. Trauma. In: Love S, Louis DN, Ellison DW, eds. Greenfield's neuropathology. 8th edn. London: Hodder Arnold, 2008:733-832.
28. Hahn AF, Hartung HP, Dyck PJ Chronic inflammatory demyelinating polyradiculoneuropathy. In: Dyck PJ, Thomas PK, eds. Peripheral neuropathy. 4th edn. Philadelphia, PA: Elsevier Saunders, 2005:2221-53.
29. Hashemi RH, Bradley WG Jr, Lisanti CJ, eds. MRI: the basics. 2nd edn. Philadelphia, PA: Lippincott Williams & Wilkins, 2004.
30. Viddeleer AR, Sijens PE, van Ooyen PMA, et al. Sequential MR imaging of denervated and reinnervated skeletal muscle as correlated to functional outcome. Radiology 2012;264:522-30.
31. Rajabally YA, Nicolas G, Piéret F, et al Validity of diagnostic criteria for chronic inflammatory demyelinating polyneuropathy: a multicentre European study. J Neurol Neurosurg Psychiatry 2009;80:1364-8.
32. Tackenberg B, Lünemannn JD, Steinbrecher A., et al Classifications and treatment responses in chronic immune-mediated demyelinating polyneuropathy. Neurology 2007;68:1622-9. (Pubitemid 46717989)